Package 68462-746-17

{"route": ["TOPICAL"], "spl_id": "091cd2ff-6773-415a-9529-4f8386512c41", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0368462746356"], "unii": ["X4HES1O11F"], "rxcui": ["197312"], "spl_set_id": ["149f4418-7668-4d34-a6f9-69bf3a9c5049"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (68462-746-17)  / 15 g in 1 TUBE", "package_ndc": "68462-746-17", "marketing_start_date": "20170731"}, {"sample": false, "description": "1 TUBE in 1 CARTON (68462-746-35)  / 30 g in 1 TUBE", "package_ndc": "68462-746-35", "marketing_start_date": "20170731"}], "brand_name": "acyclovir", "product_id": "68462-746_091cd2ff-6773-415a-9529-4f8386512c41", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68462-746", "generic_name": "acyclovir", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA205510", "marketing_category": "ANDA", "marketing_start_date": "20170731", "listing_expiration_date": "20271231"}